Next Level Private’s iShares Biotechnology ETF IBB Stock Holding History

Next Level Private’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Hold	1,193	–	–	0.04%	163
2026 Q1	$201K	Buy	1,193 +1	+0.1%	+$171	0.05%	171
2025 Q4	$201K	Buy	+1,192	New	+$194K	0.05%	158
2022 Q3	–	Sell	-3,021	Closed	-$355K	–	117
2022 Q2	$355K	Buy	+3,021	New	+$359K	0.14%	109

Other funds holding IBB

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

FNFDCM

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

RFA

Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SCA

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

Next Level Private's IBB Position: Q2 2026 in Review

Next Level Private held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,193 shares worth $227K. The position accounts for 0.04% of the portfolio, ranked #163.

Next Level Private first reported a position in IBB in Q2 2022 and has held it in 4 quarters since. The position peaked at $355K in Q2 2022. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Next Level Private held 1,193 shares of iShares Biotechnology ETF worth $227K as of Q2 2026.
Next Level Private left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.04% of Next Level Private's portfolio in Q2 2026, its #163 holding.
Next Level Private first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 4 quarters since.
Next Level Private's iShares Biotechnology ETF position peaked at $355K in Q2 2022.
158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.